CL

Laboratorios Andromaco S.a.

USPTO Granted Patents = 7

% Expired Patents = 42.9



Forward Citations = 9

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Juan Pablo Pivel Ranieri (2 out of 5 patents)

silverMedal Shu-Chen Chen (2 out of 3 patents)

bronzeMedal Fernando Gonzalo Romero Mejia (2 out of 2 patents)

4.  Aurora Brieva Delgado (1 out of 3 patents)

5.  German Arzobindo Campos Perez (1 out of 1 patent)

6.  Marianela Del Carmen Beltran Apablaza (1 out of 2 patents)

7.  Raul Patricio Salvatici Salazar (1 out of 1 patent)

8.  Antonio Miranda (1 out of 1 patent)

9.  Antonio Guerrero Gomez-Pamo (1 out of 4 patents)

10.  Raúl Sanchez Gutierrez (1 out of 1 patent)

11.  Eduardo Bustos Obregón (1 out of 1 patent)

12.  Antonio De Miranda (1 out of 2 patents)

13.  Andrés Rudolphy Fontaine (1 out of 1 patent)

14.  Jesus A Armendariz (1 out of 1 patent)

15.  Luis C Llamas (1 out of 1 patent)


7 patents:

Company Overview
Laboratorios Andromaco S.a. is a leading pharmaceutical company in Chile with a focus on developing innovative and high-quality medicines. With a strong commitment to research and development, Andromaco offers a wide range of products across various therapeutic areas. The company is dedicated to improving the health and well-being of its customers through effective and safe pharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#1 in

#18 in Chile

CL
CL
Forward Citations = 9

24 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Laboratorios Andromaco S.a.. Retrieved from https://idiyas.com/company/laboratorios-andromaco-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…